Zobrazeno 1 - 10
of 29
pro vyhledávání: '"K. M. de Bruijn"'
Publikováno v:
Natural Hazards and Earth System Sciences, Vol 16, Iss 1, Pp 1-14 (2016)
This paper addresses the large differences that are found between damage estimates of different flood damage models. It explains how implicit assumptions in flood damage functions and maximum damages can have large effects on flood damage estimates.
Externí odkaz:
https://doaj.org/article/179fdbcc35dd401f93449ed73ce1762c
Publikováno v:
Natural Hazards and Earth System Sciences, Vol 15, Iss 6, Pp 1297-1309 (2015)
For comprehensive flood risk management, accurate information on flood hazards is crucial. While in the past an estimate of potential flood consequences in large areas was often sufficient to make decisions on flood protection, there is currently an
Externí odkaz:
https://doaj.org/article/a1b9f606d91d4e6e893962bef6551eed
Publikováno v:
Natural Hazards and Earth System Sciences, Vol 14, Iss 10, Pp 2767-2781 (2014)
This paper discusses a new method for flood risk assessment in river deltas. Flood risk analysis of river deltas is complex, because both storm surges and river discharges may cause flooding and the effect of upstream breaches on downstream water lev
Externí odkaz:
https://doaj.org/article/1497c3b304624a5baa57ab626e37a688
Publikováno v:
Risk analysis : an official publication of the Society for Risk Analysis. 37(1)
As flood risks grow worldwide, a well-designed insurance program engaging various stakeholders becomes a vital instrument in flood risk management. The main challenge concerns the applicability of standard approaches for calculating insurance premium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9095a025e5c53a81d3d0451f00ab83b7
https://pubmed.ncbi.nlm.nih.gov/26970188
https://pubmed.ncbi.nlm.nih.gov/26970188
Autor:
M. Nooy, G. H. M. van der Linden, K. M. de Bruijn, C. van der Heul, W.T.A. van der Graaf, L. Siegenbeek van Heukelom, E.G.E. de Vries, A.N.M. Wymenga, J. A. Wils, A. C. Dullemond-Westland
Publikováno v:
Annals of Oncology. 7:505-510
Background: This study compares efficacy safety and tolerability of 2 and 5 mg tropisetron in prevention of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy. Patients and methods: 152 chemotherapy-naive canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb152ef1dab549290100cd7808c7200c
https://doi.org/10.1093/oxfordjournals.annonc.a010640
https://doi.org/10.1093/oxfordjournals.annonc.a010640
Autor:
C.W. Trask, M Adams, E. Rüfenacht, M Soukop, V Barley, K M de Bruijn, Heather Anderson, H Yosef, E Boesen
Publikováno v:
Anti-Cancer Drugs. 6:514-521
This study compared the efficacy and tolerability of tropisetron (Navoban, Novaban) alone or in combination with dexamethasone for the treatment of emesis induced by moderately emetogenic non-cisplatin chemotherapy. In total, 126 patients with cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe4fed25d122d91ed842c8d1dc26f3d
https://doi.org/10.1097/00001813-199508000-00004
https://doi.org/10.1097/00001813-199508000-00004
Autor:
P. Carles, Pierre Fournel, M. Marty, K M de Bruijn, A. Vergnenegre, Loria-Kanza Y, J-P Kleisbauer, C. Simonetta
Publikováno v:
Anti-Cancer Drugs. 6:15-21
The purpose of this study was to evaluate and compare the antiemetic effectiveness and tolerability of Navoban® (tropisetron) and Zofran® (ondansetron) following high-dose (≥ 50 mg/m2) cisplatin chemotherapy. In a randomised, multi-centre, double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::713aa0947b03421db9842ef3185e3801
https://doi.org/10.1097/00001813-199502001-00004
https://doi.org/10.1097/00001813-199502001-00004
Autor:
J. Michel, K. M. de Bruijn, Lambert Stamatakis, S. Van Belle, Veronique Cocquyt, Harry Bleiberg
Publikováno v:
Annals of Oncology. 5:821-825
Summary Background The purpose of these two studies was to define the optimal therapeutic dose of the 5-HT3 receptor antagonist tropisetron (Navoban®, ICS 205–930) in cisplatin-induced nausea and vomiting. Patients and methods In two multicentre,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ddb2fc676eaed9fd0ce2aee979de92
https://doi.org/10.1093/oxfordjournals.annonc.a059011
https://doi.org/10.1093/oxfordjournals.annonc.a059011
Autor:
Thomas Högberg, I. Räisänen, B T Sörensen, Bengt Sorbe, K. M. de Bruijn, L Wernstedt, Olfred Hansen, Bengt Glimelius, M Schmidt, A. van Oosterom
Publikováno v:
Cancer. 73:445-454
BACKGROUND: Chemotherapy-induced emesis is one of the most disturbing side effects in cancer therapy. Thus, antiemetic treatment is a mandatory adjunct in emetogenic chemotherapy.METHODS: Tropisetron (Navoban, Sandoz Pharma Ltd., Basel, Switzerland),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9009646faa82614c80703414d74a255f
https://doi.org/10.1002/1097-0142(19940115)73:2<445::aid-cncr2820730233>3.0.co
https://doi.org/10.1002/1097-0142(19940115)73:2<445::aid-cncr2820730233>3.0.co